Roche's Ebola Virus Test Could Be Fast-Tracked by FDA

Laboratories who want to handle Ebola samples would have to meet specific safety requirements.

Roche Holding AG wants their Ebola virus test approved for emergency use in the United States, according to Reuters.

Roland Diggelman, the company’s head of diagnostics, said Roche is in discussions for an emergency use application by the FDA, and that they also filed for CE mark approval by the European Union.

According to the report, it takes about two hours for their test to detect Ebola, and using their Roche LightCycler 480 machine, it is possible to run about 480 samples per day.

Laboratories that want to handle the samples will be required to fulfill specific safety requirements. It was not immediately clear what those safety requirements would be. 

Fresh from the show floor: pharma packaging innovations for 2026
Serialization mandates. Containment demands. Sterile barrier requirements. Our editors found the pharma packaging innovations addressing your biggest challenges at PACK EXPO Las Vegas. Get your free curated report now.
GET YOUR COPY
Fresh from the show floor: pharma packaging innovations for 2026
Recyclable pill bottles are gaining pharmacy ground
Aluminum and paper-based prescription bottles are moving from concept to commercial reality. Here's what pharmacy and packaging leaders need to know.
Read More
Recyclable pill bottles are gaining pharmacy ground